0 0 false false false false true false false false false false false true false false true true true true true true true 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 12,696,314 12,696,314 93,551 17,089,069 16,995,518 xbrli:pure xbrli:shares iso4217:GBP 07183575 2024-01-01 2024-12-31 07183575 2024-12-31 07183575 2023-12-31 07183575 2023-01-01 2023-12-31 07183575 2023-12-31 07183575 2022-12-31 07183575 core:NetGoodwill 2024-01-01 2024-12-31 07183575 bus:RegisteredOffice 2024-01-01 2024-12-31 07183575 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 07183575 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 07183575 bus:Director1 2024-01-01 2024-12-31 07183575 bus:Director5 2024-01-01 2024-12-31 07183575 core:WithinOneYear 2024-12-31 07183575 core:WithinOneYear 2023-12-31 07183575 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 07183575 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 07183575 core:ContinuingOperations 2024-01-01 2024-12-31 07183575 core:DiscontinuedOperations 2024-01-01 2024-12-31 07183575 core:ContinuingOperations 2023-01-01 2023-12-31 07183575 core:DiscontinuedOperations 2023-01-01 2023-12-31 07183575 core:AfterOneYear 2024-12-31 07183575 core:AfterOneYear 2023-12-31 07183575 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 07183575 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 07183575 core:UKTax 2024-01-01 2024-12-31 07183575 core:UKTax 2023-01-01 2023-12-31 07183575 core:ShareCapital 2024-12-31 07183575 core:ShareCapital 2023-12-31 07183575 core:RetainedEarningsAccumulatedLosses 2024-12-31 07183575 core:RetainedEarningsAccumulatedLosses 2023-12-31 07183575 core:ShareCapital 2022-12-31 07183575 core:RetainedEarningsAccumulatedLosses 2022-12-31 07183575 core:BetweenOneFiveYears 2023-12-31 07183575 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 07183575 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 07183575 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 07183575 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 07183575 core:TaxLossesCarry-forwardsDeferredTax 2024-12-31 07183575 core:TaxLossesCarry-forwardsDeferredTax 2023-12-31 07183575 core:ProvisionsDeferredTax 2024-12-31 07183575 core:ProvisionsDeferredTax 2023-12-31 07183575 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 07183575 bus:MediumEntities 2024-01-01 2024-12-31 07183575 bus:Audited 2024-01-01 2024-12-31 07183575 bus:Medium-sizedCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07183575 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07183575 bus:FullAccounts 2024-01-01 2024-12-31 07183575 bus:OrdinaryShareClass1 2024-12-31 07183575 bus:OrdinaryShareClass1 2023-12-31 07183575 core:LandBuildings core:LongLeaseholdAssets 2024-01-01 2024-12-31 07183575 core:PlantMachinery 2024-01-01 2024-12-31 07183575 core:FurnitureFittings 2024-01-01 2024-12-31 07183575 core:MotorVehicles 2024-01-01 2024-12-31 07183575 core:ContinuingOperations 1 2024-01-01 2024-12-31 07183575 1 2024-01-01 2024-12-31 07183575 1 2023-01-01 2023-12-31 07183575 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 07183575 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 07183575 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 07183575
INIVOS LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 December 2024
INIVOS LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2024
Contents
Page
Officers and professional advisers
1
Strategic report
2
Directors' report
3
Independent auditor's report to the member
5
Statement of comprehensive income
9
Statement of financial position
10
Statement of changes in equity
11
Notes to the financial statements
12
INIVOS LIMITED
OFFICERS AND PROFESSIONAL ADVISERS
The board of directors
W Fentiman
M Fentiman
Registered office
Ashurst House
Bakewell Road
Orton Southgate
Peterborough
England
PE2 6YS
Auditor
Streets Audit LLP
Chartered accountants & statutory auditor
Windsor House
A1 Business Park at
Long Bennington
Notts
NG23 5JR
INIVOS LIMITED
STRATEGIC REPORT
YEAR ENDED 31 DECEMBER 2024
Principal activities Inivos Limited has no trading within the financial year of 2024 as during 2023 the operations of Inivos Limited were transferred out of Inivos Limited to fellow group companies. Business review and results As part of our continued strategy to create a series of independently operated and well-focussed businesses, during the first six months of 2023 concluded a re-organisation of the group of companies within which Inivos Limited is a subsidiary. As a result of this re-organisation, the businesses within Inivos Limited were transferred into separate new companies. The ultimate ownership of these new companies after the transfers was unchanged. During the year the company impaired £11.3m of amounts owed by group companies which were formally waived in 2025. Principal risks and uncertainties The Board monitors the impact of economic headwinds on the business, and seeks to protect employees, customers and suppliers where practical.
This report was approved by the board of directors on 16 September 2025 and signed on behalf of the board by:
W Fentiman
Director
Registered office:
Ashurst House
Bakewell Road
Orton Southgate
Peterborough
England
PE2 6YS
INIVOS LIMITED
DIRECTORS' REPORT
YEAR ENDED 31 DECEMBER 2024
The directors present their report and the financial statements of the company for the year ended 31 December 2024 .
Directors
The directors who served the company during the year were as follows:
W Fentiman
M Fentiman
Dividends
The directors do not recommend the payment of a dividend.
Disclosure of information in the strategic report
The company has chosen to set out in the strategic report information about the results for the year, principal risks and uncertainties and the future developments of the company.
Directors' responsibilities statement
The directors are responsible for preparing the strategic report, directors' report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: - select suitable accounting policies and then apply them consistently; - make judgments and accounting estimates that are reasonable and prudent; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
This report was approved by the board of directors on 16 September 2025 and signed on behalf of the board by:
W Fentiman
Director
Registered office:
Ashurst House
Bakewell Road
Orton Southgate
Peterborough
England
PE2 6YS
INIVOS LIMITED
INDEPENDENT AUDITOR'S REPORT TO THE MEMBER OF INIVOS LIMITED
YEAR ENDED 31 DECEMBER 2024
Opinion
We have audited the financial statements of Inivos Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was that we identified the material laws and regulations applicable to the company through discussions with management, and from our commercial knowledge and experience of the company and the medical scientific support sector in which it operates. We then assessed the extent of compliance with these laws and regulations through making enquiries of management. We then assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations. To address the risk of fraud through management bias and override of controls we tested journal entries to identify unusual transactions, we assessed whether judgements and assumptions made in determining the accounting estimates set out in Note 3 were indicative of potential bias; and we investigated the rationale behind significant or unusual transactions. In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to agreeing financial statement disclosures to underlying supporting documentation, reading the minutes of meetings of those charged with governance, enquiring with management as to actual and potential litigation and claims, direct discussions and correspondence with legal advisers, and reviewing correspondence with HMRC and relevant regulators. There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. Use of our report
This report is made solely to the company's member, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member as a body, for our audit work, for this report, or for the opinions we have formed.
Mark Bradshaw
(Senior Statutory Auditor)
For and on behalf of
Streets Audit LLP
Chartered accountants & statutory auditor
Windsor House
A1 Business Park at
Long Bennington
Notts
NG23 5JR
17 September 2025
INIVOS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
YEAR ENDED 31 DECEMBER 2024
2024
2023
Continuing operations
Discont'd operations
Total
Continuing operations
Discont'd operations
Total
Note
£
£
£
£
£
£
Turnover
4
38,134
16,356,641
16,394,775
Cost of sales
( 13,510,847)
( 13,510,847)
----
----
----
--------
-------------
-------------
Gross profit
38,134
2,845,794
2,883,928
Administrative expenses
( 541,775)
( 541,775)
( 936,494)
( 2,242,251)
( 3,178,745)
Exceptional items
( 12,085,127)
( 12,085,127)
-------------
----
-------------
---------
------------
------------
Operating loss
5
( 12,626,902)
( 12,626,902)
( 898,360)
603,543
( 294,817)
Gain on impairment or disposal of operations
16,485,526
16,485,526
Other interest receivable and similar income
9
5,576
5,576
42,993
42,993
Interest payable and similar expenses
10
( 1,954)
( 1,954)
( 1,022)
( 1,022)
-------------
----
-------------
---------
-------------
-------------
(Loss)/profit before taxation
( 12,623,280)
( 12,623,280)
( 856,389)
17,089,069
16,232,680
Tax on (loss)/profit
11
( 73,034)
( 73,034)
762,838
762,838
-------------
----
-------------
---------
-------------
-------------
(Loss)/profit for the financial year and total comprehensive income
( 12,696,314)
( 12,696,314)
( 93,551)
17,089,069
16,995,518
-------------
----
-------------
---------
-------------
-------------
INIVOS LIMITED
STATEMENT OF FINANCIAL POSITION
31 December 2024
2024
2023
Note
£
£
Fixed assets
Intangible assets
12
58,909
89,411
Current assets
Debtors
13
20,312,664
27,682,937
Cash at bank and in hand
142,184
687,471
-------------
-------------
20,454,848
28,370,408
Creditors: amounts falling due within one year
14
( 7,304,970)
( 2,554,718)
-------------
-------------
Net current assets
13,149,878
25,815,690
-------------
-------------
Total assets less current liabilities
13,208,787
25,905,101
-------------
-------------
Net assets
13,208,787
25,905,101
-------------
-------------
Capital and reserves
Called up share capital
16
5
5
Profit and loss account
17
13,208,782
25,905,096
-------------
-------------
Shareholder funds
13,208,787
25,905,101
-------------
-------------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the medium companies regime.
These financial statements were approved by the board of directors and authorised for issue on 16 September 2025 , and are signed on behalf of the board by:
W Fentiman
Director
Company registration number: 07183575
INIVOS LIMITED
STATEMENT OF CHANGES IN EQUITY
YEAR ENDED 31 DECEMBER 2024
Called up share capital
Profit and loss account
Total
£
£
£
At 1 January 2023
5
9,614,578
9,614,583
Profit for the year
16,995,518
16,995,518
----
-------------
-------------
Total comprehensive income for the year
16,995,518
16,995,518
Investments by and distributions to group companies
( 705,000)
( 705,000)
----
-------------
-------------
Total investments by and distributions to owners
( 705,000)
( 705,000)
At 31 December 2023
5
25,905,096
25,905,101
Loss for the year
( 12,696,314)
( 12,696,314)
----
-------------
-------------
Total comprehensive income for the year
( 12,696,314)
( 12,696,314)
----
-------------
-------------
At 31 December 2024
5
13,208,782
13,208,787
----
-------------
-------------
INIVOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ashurst House, Bakewell Road, Orton Southgate, Peterborough, PE2 6YS, England.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis and in sterling which is the functional currency of the entity.
Going concern
The financial statements have been prepared on a going concern basis. The directors have considered relevant information including the significant reserves of the company in making this assessment, and the directors can call on other group companies to settle balances if cash is required. Based on these assessments, the directors have concluded that there is no material uncertainty and that they can continue to adopt the going concern basis in preparing the financial statements.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. Its financial statements are consolidated into the financial statements of Specialist Health Solutions Limited which can be obtained from the registered office. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) Disclosures in respect of each class of share capital have not been presented. (b) No cash flow statement has been presented for the company. (c) Disclosures in respect of financial instruments have not been presented. (e) No disclosure has been given for the aggregate remuneration of key management personnel.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The actual outcome may diverge from these estimates if other assumptions are made, or other conditions arise. - Significant judgements The directors have impaired balances owed by group companies where these have been formally waived after the year end. - Key sources of estimation uncertainty Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The only key assumption and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are the depreciation and amortisation charges. These are sensitive to changes in the useful economic lives and residual values of the asset and are reviewed periodically by the Directors to ensure that they reflect both external and internal factors.
Revenue recognition
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Revenue from maintenance contracts are recognised over the period to which they relate. Revenue from design and build contracts is recognised as a percentage of costs incurred. Revenue is recognised on construction services over time as benefit is transferred to the customer. The Company uses an input method to measure progress. The percentage of completion is measured using cost incurred to date as a proportion of the estimated full costs of completing the contract and is applied to the expected contract revenue to determine the revenue and profit to be recognised to date.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
10% straight line
Patents, trademarks and licences
-
12.5% straight line
Website
-
33% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Research expenditure is written off in the period in which it is incurred.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Property improvements
-
20% to 33% straight line
Plant and machinery
-
25% to 33% straight line
Office equipment
-
25% straight line
Motor vehicles
-
25% straight line
Property improvements are depreciated from the date the units are brought in to use.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
The company only holds basic financial instruments as defined in FRS 102. The financial assets and financial liabilities of the company and their measurement basis are as follows: Financial assets - trade and other debtors are basic financial instruments and are debt instruments measured at amortised cost. Prepayments are not financial instruments. Cash at bank is classified as a basic financial instrument and is measured at amortised cost. Financial liabilities - trade creditors, accruals and other creditors are financial instruments, and are measured at amortised cost. Taxation and social security are not included in the financial instruments disclosure definition.
4. Turnover
Turnover arises from:
2024
2023
£
£
Sale of goods
1,451,031
Rendering of services
14,943,744
----
-------------
16,394,775
----
-------------
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5. Operating loss
Operating profit or loss is stated after charging:
2024
2023
£
£
Amortisation of intangible assets
30,502
28,801
Depreciation of tangible assets
193,207
Impairment of trade debtors
89,191
Research and development expenditure written off
86,684
Foreign exchange differences
5,408
19,528
Operating lease costs
227,663
--------
---------
6. Auditor's remuneration
2024
2023
£
£
Fees payable for the audit of the financial statements
7,500
13,000
-------
--------
7. Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:
2024
2023
No.
No.
Production staff
34
Administrative staff
9
Management staff
2
----
----
45
----
----
The aggregate payroll costs incurred during the year, relating to the above, were:
2024
2023
£
£
Wages and salaries
1,079,678
Social security costs
126,104
----
------------
1,205,782
----
------------
8. Exceptional items
Exceptional items includes £11,314,546 impairment of amounts owed by group undertakings which were formally waived in 2025, and £770,581 of legal fees.
9. Other interest receivable and similar income
2024
2023
£
£
Interest on cash and cash equivalents
5,576
330
Other interest receivable and similar income
42,663
-------
--------
5,576
42,993
-------
--------
10. Interest payable and similar expenses
2024
2023
£
£
Interest on obligations under finance leases and hire purchase contracts
1,022
Other interest payable and similar charges
1,954
-------
-------
1,954
1,022
-------
-------
11. Tax on (loss)/profit
Major components of tax expense/(income)
2024
2023
£
£
Current tax:
UK current tax income
( 112,435)
( 399,946)
Adjustments in respect of prior periods
399,946
---------
---------
Total current tax
287,511
( 399,946)
---------
---------
Deferred tax:
Origination and reversal of timing differences
( 214,477)
( 362,892)
---------
---------
Tax on (loss)/profit
73,034
( 762,838)
---------
---------
Reconciliation of tax expense/(income)
The tax assessed on the (loss)/profit on ordinary activities for the year is higher than (2023: lower than) the standard rate of corporation tax in the UK of 25 % (2023: 23.52 %).
2024
2023
£
£
(Loss)/profit on ordinary activities before taxation
( 12,623,280)
16,232,680
-------------
-------------
(Loss)/profit on ordinary activities by rate of tax
( 3,155,820)
3,818,015
Adjustment to tax charge in respect of prior periods
399,946
Effect of expenses not deductible for tax purposes
2,832,611
12,696
Effect of capital allowances and depreciation
( 3,703)
7,080
Utilisation of tax losses
( 260,358)
Unused tax losses
( 258,905)
Rounding on tax charge
( 6,154)
Effect of research and development
( 14,615)
Other tax adjustment on transfer of trades
( 4,060,597)
-------------
-------------
Tax on (loss)/profit
73,034
( 762,838)
-------------
-------------
12. Intangible assets
Patents, trademarks and licences
Website
Total
£
£
£
Cost
At 1 January 2024 and 31 December 2024
212,379
18,870
231,249
---------
--------
---------
Amortisation
At 1 January 2024
122,968
18,870
141,838
Charge for the year
30,502
30,502
---------
--------
---------
At 31 December 2024
153,470
18,870
172,340
---------
--------
---------
Carrying amount
At 31 December 2024
58,909
58,909
---------
--------
---------
At 31 December 2023
89,411
89,411
---------
--------
---------
13. Debtors
2024
2023
£
£
Trade debtors
9,230
41,822
Amounts owed by group undertakings
18,747,302
26,304,277
Deferred tax asset
1,507,907
1,293,430
Prepayments and accrued income
163
11,050
Other debtors
48,062
32,358
-------------
-------------
20,312,664
27,682,937
-------------
-------------
The debtors above include the following amounts falling due after more than one year:
2024
2023
£
£
Amounts owed by group undertakings
2,785,454
14,100,000
------------
-------------
Amounts owed by group undertakings of £15,961,848 are repayable on demand and no interest is charged.
14. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
283,099
98,481
Amounts owed to group undertakings
4,581,295
Accruals and deferred income
2,434,857
2,413,357
Social security and other taxes
31,572
Other creditors
5,719
11,308
------------
------------
7,304,970
2,554,718
------------
------------
Hire purchase agreements are secured against the assets to which they relate.
Amounts owed to group undertakings are repayable on demand and no interest is charged.
15. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2024
2023
£
£
Included in debtors (note 13)
1,507,907
1,293,430
------------
------------
The deferred tax account consists of the tax effect of timing differences in respect of:
2024
2023
£
£
Accelerated capital allowances
( 20,051)
( 22,917)
Unused tax losses
( 884,088)
( 666,746)
Provisions
( 603,768)
( 603,767)
------------
------------
(1,507,907)
(1,293,430)
------------
------------
The deferred tax asset is expected to unravel in the next few years as the losses are utilised against future forecast profits within the group and accruals and provisions are released.
16. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
5
5
5
5
----
----
----
----
17. Reserves
Profit and loss account - This reserve records retained earnings and accumulated losses.
18. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2024
2023
£
£
Not later than 1 year
192,041
Later than 1 year and not later than 5 years
144,971
----
---------
337,012
----
---------
Operating leases have been novated to another group company .
19. Related party transactions
Loans exist with companies owned by a former director and shareholder. At the year end the company was owed £13,103 (2023 - £12,169) by those entities. The directors have taken advantage of the exemption in FRS102 from disclosing related party transactions with group companies on the grounds that the company is a subsidiary undertaking where 100% of the voting rights are controlled within the group, and the consolidated financial statements in which the company is included are publicly available. No other material transactions arose which are required to be disclosed under FRS 102.
20. Controlling party
The immediate parent undertaking is Specialist Health Solutions Limited . Copies of the Specialist Health Solutions Limited consolidated financial statements can be obtained from the registered office Ashurst House, Bakewell Road, Orton Southgate, Peterborough, England, PE2 6YS . The ultimate controlling party is W Fentiman .